At 82 years old, and with a sprawling resume worthy of its own Wikipedia entry, Malcolm McDowell isn’t afraid to speak freely ...

Bristol Myers Squibb, Merck & Company, and GE Healthcare Technologies continue advancing the cancer care ecosystem through ...

Columbia Threadneedle’s Disciplined Core Fund returned 9.54% in Q2 2025, led by AI-fueled tech picks. Discover how stock ...

What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...

PD-1 inhibitors are projected to dominate future drug sales. Immuno-oncology therapies, particularly the PD-(L)1 class, have revolutionized cancer ca ...

New Jersey officials are eyeing several efforts, including a massive $500 million incentive program meant to entice more ...

Columbia Threadneedle Investments reports Q2 underperformance for its Dividend Income Fund amid tech and healthcare headwinds ...